跳至主要内容
临床试验/NCT04662814
NCT04662814已完成不适用

the Efficacy of Extracorporeal Shock Wave Therapy for Primary Dysmenorrhea

MTI University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
numerical rating scale

研究概览

简要总结

purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea

详细描述

This randomized controlled trial is to determine the effect of shock wave therapy in the treatment of primary dysmenorrhea.

females are randomly assigned into 2 groups: group A SWT treatment plus dietary modification during PD (n=25) GROUP B:dietary modification only (n=25);

Participants in group B will receive dietary modification for three successive months

The numerical rating scale (NRS) and prostaglandin blood level will be recorded and evaluated before and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ages ranged between18 - 25 years old.
  • body mass index (BMI) will not exceed 30kg/m
  • females will be diagnosed by the physician as primary dysmenorrhea.

排除标准

  • Secondary dysmenorrhea .
  • Mental health problem such as depression and anxiety.
  • Irregular periods

结局指标

主要结局

numerical rating scale

时间窗: 3 months

Numeric rating scale will be 10 cm digital line with 0 (zero) representing feeling no pain and 10 representing feeling the worst pain, was used to assess the severity of the pain before and after treatment for all females in both groups (A\&B). measurement will done twice first one at baseline(will be considered as pre treatment measure) and 2nd on e at 3rd menstrual cycle ( will be considered as post treatment measure)

次要结局

  • prostaglandin(3months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

shaimaa Mohamed hamed

principle investigator

MTI University

研究点 (1)

Loading locations...

相似试验

Extracorporeal Shock Wave Therapy for Dysmenorrhea | 临床试验